Sartorius (OTCMKTS:SARTF – Get Free Report) was the target of a significant drop in short interest in the month of October. As of October 30th, there was short interest totaling 836 shares, a drop of 54.2% from the October 15th total of 1,827 shares. Approximately 0.0% of the shares of the company are short sold. Based on an average trading volume of 0 shares, the days-to-cover ratio is presently ∞ days.
Sartorius Stock Performance
SARTF stock remained flat at $261.99 during midday trading on Monday. The business has a fifty day moving average price of $241.61 and a two-hundred day moving average price of $224.03. The company has a quick ratio of 0.49, a current ratio of 0.95 and a debt-to-equity ratio of 0.89. Sartorius has a 1-year low of $181.58 and a 1-year high of $261.99. The company has a market cap of $8.97 billion, a P/E ratio of 121.85 and a beta of 0.98.
Sartorius Company Profile
Sartorius is a life science company headquartered in Göttingen, Germany. Founded in 1870 as a precision-balance manufacturer, it has grown into a global supplier of technologies and services for biopharmaceutical production and laboratory research. The company’s bioprocessing products include filtration and fluid-management systems, single-use equipment, bioreactors, and technologies used in cell culture and purification. These solutions support the development and manufacture of biologic medicines, including vaccines and other advanced therapies.
See Also
- Five stocks we like better than Sartorius
- Ondas Is Building a Defense Growth Engine, But Can It Deliver on Its Backlog?
- Orbiting Growth: Federal Contracts Boost Viasat’s Outlook
- Modine Manufacturing Scales Up to Solve the AI Heat Problem
- Nebius Revenue Is Surging, But Its Spending Is Raising Bigger Questions
Receive News & Ratings for Sartorius Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sartorius and related companies with MarketBeat.com's FREE daily email newsletter.
